These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23214064)

  • 1. [Management of Graves' ophthalmopathy by using orbital magnetic resonance imaging].
    Hiromatsu Y; Eguchi H; Tani J
    Nihon Rinsho; 2012 Nov; 70(11):1932-7. PubMed ID: 23214064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
    Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
    Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Graves'ophthalmopathy: usefulness of T2 weighted muscle signal intensity].
    Sillaire I; Ravel A; Dalens H; Garcier JM; Boyer L
    J Radiol; 2003 Feb; 84(2 Pt 1):139-42. PubMed ID: 12717285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy--a pilot study at 1.5 T.
    Kirsch EC; Kaim AH; De Oliveira MG; von Arx G
    Neuroradiology; 2010 Feb; 52(2):91-7. PubMed ID: 19756565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.
    Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L
    Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of extraocular muscle with high-field magnetic resonance in patients with Graves' ophthalmopathy with upper-lid retraction.
    Chen Y; Jin ZY; Zhang ZH; Xu DD; Meng W; Jiang B; Fang HY; Sun ZY; Chen Y; Sun HY; Feng F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):461-7. PubMed ID: 23134821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease.
    Mayer EJ; Fox DL; Herdman G; Hsuan J; Kabala J; Goddard P; Potts MJ; Lee RW
    Eur J Radiol; 2005 Oct; 56(1):20-4. PubMed ID: 15896938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance evaluation of disease activity in Graves' ophthalmopathy: T2-time and signal intensity of extraocular muscles.
    Majos A; Pajak M; Grzelak P; Stefańczyk L
    Med Sci Monit; 2007 May; 13 Suppl 1():44-8. PubMed ID: 17507884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prediction for effectiveness of steroid pulse therapy by MRI in Graves' ophthalmopathy].
    Sato M; Hiromatsu Y; Tanaka K; Nonaka K; Kojima K; Nishimura H; Nishida H
    Nihon Naibunpi Gakkai Zasshi; 1992 Mar; 68(3):143-53. PubMed ID: 1582520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy.
    Li Z; Luo Y; Feng X; Zhang Q; Zhong Q; Weng C; Chen Z; Shen J
    J Magn Reson Imaging; 2023 Oct; 58(4):1279-1289. PubMed ID: 36780178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].
    Hosten N; Cordes M; Sander B; Schörner W; Wenzel KW; Felix R
    Rofo; 1990 Apr; 152(4):388-92. PubMed ID: 2160096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.
    Ohnishi T; Noguchi S; Murakami N; Tajiri J; Harao M; Kawamoto H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S
    Radiology; 1994 Mar; 190(3):857-62. PubMed ID: 8115640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
    Hosten N; Schörner W; Lietz A; Wenzel KW
    Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
    Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graves ophthalmopathy: MR imaging of the orbits.
    Hosten N; Sander B; Cordes M; Schubert CJ; Schörner W; Felix R
    Radiology; 1989 Sep; 172(3):759-62. PubMed ID: 2772184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images.
    Mirowitz SA; Apicella P; Reinus WR; Hammerman AM
    AJR Am J Roentgenol; 1994 Jan; 162(1):215-21. PubMed ID: 8273669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of T2 mapping in the staging of Graves' ophthalmopathy based on different region of interest selection methods.
    Yang L; Dai X; Su J; Yang S; Zheng Y; Ma M; Yu S
    Acta Radiol; 2024 Jul; 65(7):835-840. PubMed ID: 38767046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
    Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study.
    Das T; Roos JCP; Patterson AJ; Graves MJ; Murthy R
    Eye (Lond); 2019 Feb; 33(2):235-243. PubMed ID: 30538310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessory lateral rectus muscle in graves' orbitopathy: a case report.
    Fichter N; von Arx G; Kirsch EC
    Clin Neuroradiol; 2014 Sep; 24(3):277-9. PubMed ID: 23828403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.